THREETREND RESEARCH
4 Oct • 2:43 PM · SEBI-Registered Analyst
Morning Star is a bullish reversal candlestick pattern
Strides Pharma Science Ltd. share price is currently ₹1,077.11, down by - ₹36.64 (3.29%) from its previous closing price of ₹1,113.75. The share price has gained 6.02% over the past month and gained 29.66% over the past year. The stock's 52-week low and high are ₹759.71 and ₹1,242.07, respectively. Strides Pharma Science Ltd. has a market capitalisation of ₹ 10,920.00 Cr. The share price was last updated on 01 Oct 2026, 03:50 PM IST.

Updated: 01 Oct 2026, 03:50:01 pm IST

Mutual Fund Holder | Jul 26 Shares held | Aug 26 Shares held |
|---|---|---|
| Quant Small Cap Fund - Growth | 36.32 Lac | 36.73 Lac (1.12%) |
| Bandhan Small Cap Fund - Regular Plan - Growth | 17.97 Lac | 25.58 Lac (42.32%) |
| Quant Multi Cap Fund - Growth | 14.22 Lac | 14.22 Lac no change |
| Axis Small Cap Fund - Regular Plan - Growth | 7.35 Lac | 7.35 Lac no change |
| Aditya Birla Sun Life Value Fund - Regular Plan - Growth | 3.66 Lac | 3.66 Lac no change |
Strides Pharma Science Limited is an India-based pharmaceutical company. The Company is focused on the development and manufacture of IP-led niche finished dosage formulations. The Company operates through two segments: Pharmaceutical and Bio-pharmaceutical. Its geographical segment includes Africa, Australia, Asia (excluding India), North America, Europe, India, and Others. The Company manufactures a range of niche and pharmaceutical products, including a range of dosage forms such as liquids, creams and ointments, soft gels, sachets, tablets, and modified release dosage formats. It has eight manufacturing units located in India (Bengaluru-two sites, Puducherry, and Chennai), Singapore, Italy (Milan), the United States (Florida) and Kenya (Nairobi). It is also engaged in manufacturing soft gelatin capsules. It develops and manufactures drugs in the anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drug segments for its institutional business.
Insights from SEBI-registered analysts · updated live

Today's market leaders and laggards
Molbio Diagnostics Ltd.
MOLBIO
₹1,500.79
+209.68 (16.24%)
Thomas Scott (India) Ltd.
THOMASCOTT
₹298.72
+32.95 (12.40%)
Augmont Enterprises Ltd.
AUGMONT
₹1,182.66
+105.58 (9.80%)
Gujarat Kidney And Super Speciality Ltd.
GKSL
₹193.37
+16.76 (9.49%)
Lokesh Machines Ltd.
LOKESHMACH
₹394.61
+31.40 (8.65%)